Nektar Therapeutics (NKTR)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 04, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Profit Margin (Quarterly): -222.9% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -222.9% |
| March 31, 2024 | -170.1% |
| December 31, 2023 | -176.2% |
| September 30, 2023 | -189.8% |
| June 30, 2023 | -249.4% |
| March 31, 2023 | -634.5% |
| December 31, 2022 | -271.0% |
| September 30, 2022 | -249.9% |
| June 30, 2022 | -736.9% |
| March 31, 2022 | -364.2% |
| December 31, 2021 | -582.4% |
| September 30, 2021 | -520.5% |
| June 30, 2021 | -443.1% |
| March 31, 2021 | -520.0% |
| December 31, 2020 | -499.5% |
| September 30, 2020 | -361.6% |
| June 30, 2020 | -163.8% |
| March 31, 2020 | -274.2% |
| December 31, 2019 | -331.2% |
| September 30, 2019 | -337.4% |
| June 30, 2019 | -473.0% |
| March 31, 2019 | -423.9% |
| December 31, 2018 | -246.6% |
| September 30, 2018 | -346.3% |
| June 30, 2018 | 89.31% |
| Date | Value |
|---|---|
| March 31, 2018 | -252.0% |
| December 31, 2017 | -35.43% |
| September 30, 2017 | 39.80% |
| June 30, 2017 | -173.1% |
| March 31, 2017 | -258.3% |
| December 31, 2016 | -112.7% |
| September 30, 2016 | -119.0% |
| June 30, 2016 | -148.3% |
| March 31, 2016 | -33.11% |
| December 31, 2015 | -137.5% |
| September 30, 2015 | -13.68% |
| June 30, 2015 | -232.4% |
| March 31, 2015 | 31.08% |
| December 31, 2014 | -233.6% |
| September 30, 2014 | 53.14% |
| June 30, 2014 | -114.5% |
| March 31, 2014 | -233.7% |
| December 31, 2013 | -153.0% |
| September 30, 2013 | -27.16% |
| June 30, 2013 | -126.2% |
| March 31, 2013 | -239.4% |
| December 31, 2012 | -250.3% |
| September 30, 2012 | -236.5% |
| June 30, 2012 | -144.8% |
| March 31, 2012 | -229.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-736.9%
Minimum
Jun 2022
-163.8%
Maximum
Jun 2020
-366.4%
Average
-331.2%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Esperion Therapeutics Inc | -83.87% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -127.6% |
| Return on Assets | -42.69% |
| Return on Invested Capital | -127.6% |
| Gross Profit Margin (Quarterly) | 58.53% |
| Operating Margin (Quarterly) | -155.3% |
| Return on Net Operating Assets | -271.7% |